Adaptation of Borrelia burgdorferi in the tick and the mammalian host

FEMS Microbiology Reviews

Volumn 27, Issue 4, 2003, Pages 493-504

  Anguita, Juan ^a   Hedrick, Michael N ^a   Fikrig, Erol ^b  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Borrelia burgdorferi; Gene expression; Lyme disease; Vaccine

Indexed keywords

BACTERIAL PROTEIN;

BACTERIAL INFECTION; BACTERIAL SURVIVAL; BORRELIA BURGDORFERI; CELL DENSITY; COMPLEMENT INHIBITION; EVOLUTIONARY ADAPTATION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; HOST; HUMAN; IMMUNE RESPONSE; LIFE CYCLE; LYME DISEASE; MAMMAL; MOLECULAR MECHANICS; NONHUMAN; PARASITE PREVALENCE; PARASITE SURVIVAL; PARASITE VECTOR; REVIEW; SPIROCHETE; TICK;

ACARI; ARTHROPODA; BORRELIA; BORRELIA BURGDORFERI; MAMMALIA; SPIROCHAETALES;

EID: 0141671799     PISSN: 01686445     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-6445(03)00036-6     Document Type: Review

References (119)

1. Barbour A.G., Fish D. The biological and social phenomenon of Lyme disease. Science. 260:1993;1610-1616.
2. Schulze T.L., Bowen G.S., Lakat M.F., Parkin W.E., Shisler J.K. The role of adult Ixodes dammini (Acari: Ixodidae) in the transmission of Lyme disease in New Jersey, USA. J. Med. Entomol. 22:1985;88-93.
3. Lane R.S., Piesman J., Burgdorfer W. Lyme borreliosis: relation of its causative agent to its vectors and hosts in North America and Europe. Annu. Rev. Entomol. 36:1991;587-609.
4. Anderson J.F. Epizootiology of Borrelia in Ixodes tick vectors and reservoir hosts. Rev. Infect. Dis. 11:1989;S1451-1459.
5. Anderson J.F., Magnarelli L.A., Stafford K.C. Bird-feeding ticks transstadially transmit Borrelia burgdorferi that infect Syrian hamsters. J. Wildl. Dis. 26:1990;1-10.
6. Steere A.C., Bartenhagen N.H., Craft J.E., Hutchinson G.J., Newman J.H., Rahn D.W., Sigal L.H., Spieler P.H., Stenn K.S., Malawista S.E. The early clinical manifestations of Lyme disease. Ann. Intern. Med. 99:1983;76-82.
7. Steere A.C., Batsford W.P., Weinberg M., Alexander J., Berger H.J., Wolfson S., Malawista S.E. Lyme carditis: cardiac abnormalities of Lyme disease. Ann. Intern. Med. 93:1980;8-16.
8. Steere A.C. Lyme disease. N. Engl. J. Med. 321:1989;586.
9. Paparone P.W. Cardiovascular manifestations of Lyme disease. J. Am. Osteopath. Assoc. 97:1997;156-161.
10. Haass A., Treib J. Neurologic manifestation and classification of borreliosis. Infection. 24:1996;467-469.
11. Koch F., Stanzl U., Jennewein P., Janke K., Heufler C., Kampgen E., Romani N., Schuler G. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:1996;741-746.
12. Nadelman R.B., Nowakowski J., Forseter G., Goldberg N.S., Bittker S., Cooper D., Aguero-Rosenfeld M., Wormser G.P. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am. J. Med. 100:1996;502-508.
13. Kindstrand E. Lyme borreliosis and cranial neuropathy. J. Neurol. 242:1995;658-663.
14. Wang W.Z., Fredrikson S., Sun J.B., Link H. Lyme neuroborreliosis: evidence for persistent up-regulation of Borrelia burgdorferi-reactive cells secreting interferon-gamma. Scand. J. Immunol. 42:1995;694-700.
15. Evans J. Lyme disease. Curr. Opin. Rheumatol. 7:1995;322-328.
16. Steere, A.C. (1995) Musculoskeletal manifestations of Lyme disease. Am. J. Med. 98, 44S-48S; discussion 48S-51S.
17. Pachner A.R., Delaney E., O'Neill T. Neuroborreliosis in the nonhuman primate: Borrelia burgdorferi persists in the central nervous system. Ann. Neurol. 38:1995;667-669.
18. Nadelman, R.B. and Wormser, G.P. (1995) Erythema migrans and early Lyme disease. Am. J. Med. 98, 15S-23S; discussion 23S-24S.
19. Fallon B.A., Nields J.A. Lyme disease: a neuropsychiatric illness. Am. J. Psychiatry. 151:1994;1571-1583.
20. Logigian E.L., Kaplan R.F., Steere A.C. Chronic neurologic manifestations of Lyme disease. N. Engl. J. Med. 323:1990;1438-1444.
21. Steere A.C. Lyme disease. N. Engl. J. Med. 345:2001;115-125.
22. Evans J. Lyme disease. Curr. Opin. Rheumatol. 8:1996;327-333.
23. Pachner A.R., Duray P., Steere A.C. Central nervous system manifestations of Lyme disease. Arch. Neurol. 46:1989;790-795.
24. Barthold S.W., de Souza M.S., Janotka J.L., Smith A.L., Persing D.H. Chronic Lyme borreliosis in the laboratory mouse. Am. J. Pathol. 143:1993;959-971.
25. Schaible U.E., Wallich R., Kramer M.D., Museteanu C., Simon M.M. A mouse model for Borrelia burgdorferi infection: pathogenesis, immune response and protection. Behring Inst. Mitt. 88:1991;59-67.
26. Steere A.C., Dwyer E., Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N. Engl. J. Med. 323:1990;219-223.
27. Kalish R.A., Leong J.M., Steere A.C. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect. Immun. 61:1993;2774-2779.
28. Gross D.M., Forsthuber T., Tary-Lehmann M., Etling C., Ito K., Nagy Z.A., Field J.A., Steere A.C., Huber B.T. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science. 281:1998;703-706.
29. Yang L., Weis J.H., Eichwald E., Kolbert C.P., Persing D.H., Weis J.J. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect. Immun. 62:1994;492-500.
30. Carroll J.A., Dorward D.W., Gherardini F.C. Identification of a transferrin-binding protein from Borrelia burgdorferi. Infect. Immun. 64:1996;2911-2916.
31. Hughes C.A., Engstrom S.M., Coleman L.A., Kodner C.B., Johnson R.C. Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB. Infect. Immun. 61:1993;5115-5122.
32. Norris S.J., Howell J.K., Garza S.A., Ferdows M.S., Barbour A.G. High- and low-infectivity phenotypes of clonal populations of in vitro-cultured Borrelia burgdorferi. Infect. Immun. 63:1995;2206-2212.
33. Anguita J., Persing D.H., Rincón M., Barthold S.W., Fikrig E. Effect of anti-interleukin 12 treatment on murine Lyme borreliosis. J. Clin. Invest. 97:1996;1028-1034.
34. Brunet L.R., Spielman A., Telford S.R. Short report: density of Lyme disease spirochetes within deer ticks collected from zoonotic sites. Am. J. Trop. Med. Hyg. 53:1995;300-302.
35. Keane-Myers A., Nickell S.P. Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 155:1995;2020-2028.
36. Keane-Myers A., Nickell S.P. T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 154:1995;1770-1776.
37. Lengl-Janssen B., Strauss A.F., Steere A.C., Kamradt T. The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J. Exp. Med. 180:1994;2069-2078.
38. Matyniak J.E., Reiner S.L. T helper phenotype and genetic susceptibility in experimental Lyme disease. J. Exp. Med. 181:1995;1251-1254.
39. Szczepanski A., Benach J.L. Lyme borreliosis: host responses to Borrelia burgdorferi. Microbiol. Rev. 55:1991;21-34.
40. Yang L., Ma Y., Schoenfeld R., Griffiths M., Eichwald E., Araneo B., Weis J.J. Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice. Infect. Immun. 60:1992;3033-3041.
41. Barthold S.W., de Souza M., Feng S. Serum-mediated resolution of Lyme arthritis in mice. Lab. Invest. 74:1996;57-67.
42. + T cells. J. Immunol. 159:1997;5682-5686.
43. Simon M.M., Gern L., Hauser P., Zhong W., Nielsen P.J., Kramer M.D., Brenner C., Wallich R. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter. Eur. J. Immunol. 26:1996;2831-2840.
44. Padilla M.L., Callister S.M., Schell R.F., Bryant G.L., Jobe D.A., Lovrich S.D., DuChateau B.K., Jensen J.R. Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine. J. Infect. Dis. 174:1996;739-746.
45. Fikrig E., Barthold S.W., Chen M., Grewal I.S., Craft J., Flavell R.A. Protective antibodies in murine Lyme disease arise independently of CD40 ligand. J. Immunol. 157:1996;1-3.
46. Garcia-Monco J.C., Seidman R.J., Benach J.L. Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides. Infect. Immun. 63:1995;4130-4137.
47. Ma J., Gingrich-Baker C., Franchi P.M., Bulger P., Coughlin R.T. Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi. Infect. Immun. 63:1995;2221-2227.
48. Aydintug M.K., Gu Y., Philipp M.T. Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey. Infect. Immun. 62:1994;4929-4937.
49. Fikrig E., Bockenstedt L.K., Barthold S.W., Chen M., Tao H., Ali-Salaam P., Telford S.R., Flavell R.A. Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis. J. Infect. Dis. 169:1994;568-574.
50. Barthold S.W., Bockenstedt L.K. Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect. Immun. 61:1993;4696-4702.
51. Callister S.M., Schell R.F., Case K.L., Lovrich S.D., Day S.P. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test. J. Infect. Dis. 167:1993;158-164.
52. Barthold S.W., Feng S., Bockenstedt L.K., Fikrig E., Feen K. Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. Clin. Infect. Dis. 25:(Suppl. 1):1997;9-17.
53. Schaible U.E., Wallich R., Kramer M.D., Nerz G., Stehle T., Museteanu C., Simon M.M. Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone. Int. Immunol. 6:1994;671-681.
54. Barbour A.G. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57:1984;521-525.
55. Pollack R.J., Telford S.R., Spielman A. Standardization of medium for culturing Lyme disease spirochetes. J. Clin. Microbiol. 31:1993;1251-1255.
56. Babb K., El-Hage N., Miller J.C., Carroll J.A., Stevenson B. Distinct regulatory pathways control expression of Borrelia burgdorferi infection-associated OspC and Erp surface proteins. Infect. Immun. 69:2001;4146-4153.
57. Stevenson B., Schwan T.G., Rosa P.A. Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 63:1995;4535-4539.
58. Carroll J.A., Cordova R.M., Garon C.F. Identification of 11 pH-regulated genes in Borrelia burgdorferi localizing to linear plasmids. Infect. Immun. 68:2000;6677-6684.
59. Margolis N., Rosa P.A. Regulation of expression of major outer surface proteins in Borrelia burgdorferi. Infect. Immun. 61:1993;2207-2210.
60. Indest K.J., Ramamoorthy R., Sole M., Gilmore R.D., Johnson B.J., Philipp M.T. Cell-density-dependent expression of Borrelia burgdorferi lipoproteins in vitro. Infect. Immun. 65:1997;1165-1171.
61. Ramamoorthy R., Philipp M.T. Differential expression of Borrelia burgdorferi proteins during growth in vitro. Infect. Immun. 66:1998;5119-5124.
62. Fraser C.M., Casjens S., Huang W.M., Sutton G.G., et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature. 390:1997;580-586.
63. Pal U., de Silva A.M., Montgomery R.R., Fish D., Anguita J., Anderson J.F., Lobet Y., Fikrig E. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by Outer surface protein, A. J. Clin. Invest. 106:2000;561-569.
64. Pal U., Montgomery R.R., Lusitani D., Voet P., Weynants V., Malawista S.E., Lobet Y., Fikrig E. Inhibition of Borrelia burgdorferi-tick interactions in vivo by Outer surface protein A antibody. J. Immunol. 166:2001;7398-7403.
65. Gilmore R.D., Piesman J. Inhibition of Borrelia burgdorferi migration from the midgut to the salivary glands following feeding by ticks on OspC-immunized mice. Infect. Immun. 68:2000;411-414.
66. Ohnishi J., Piesman J., de Silva A.M. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc. Natl. Acad. Sci. USA. 98:2001;670-675.
67. Probert W.S., Johnson B.J. Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B31. Mol. Microbiol. 30:1998;1003-1015.
68. Fikrig E., Feng W., Barthold S.W., Telford S.R., Flavell R.A. Arthropod- and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmission. J. Immunol. 164:2000;5344-5351.
69. Liang F.T., Nelson F.K., Fikrig E. Molecular adaptation of Borrelia burgdorferi in the murine host. J. Exp. Med. 196:2002;275-280.
70. Fikrig E., Barthold S.W., Sun W., Feng W., Telford S.R., Flavell R.A. Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity. Immunity. 6:1997;531-539.
71. Montgomery R.R., Malawista S.E., Feen K.J., Bockenstedt L.K. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. J. Exp. Med. 183:1996;261-269.
72. Schwan T.G. Ticks and Borrelia: model systems for investigating pathogen-arthropod interactions. Infect. Agents Dis. 5:1996;167-181.
73. Schwan T.G., Simpson W.J. Factors influencing the antigenic reactivity of Borrelia burgdorferi, the Lyme disease spirochete. Scand. J. Infect. Dis. Suppl. 77:1991;94-101.
74. Hodzic E., Feng S., Freet K.J., Borjesson D.L., Barthold S.W. Borrelia burgdorferi population kinetics and selected gene expression at the host-vector interface. Infect. Immun. 70:2002;3382-3388.
75. Akin E., McHugh G.L., Flavell R.A., Fikrig E., Steere A.C. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect. Immun. 67:1999;173-181.
76. Benoist C., Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat. Immunol. 2:2001;797-801.
77. Suk K., Das S., Sun W., Jwang B., Barthold S.W., Flavell R.A., Fikrig E. Borrelia burgdorferi genes selectively expressed in the infected host. Proc. Natl. Acad. Sci. USA. 92:1995;4269-4273.
78. Anguita J., Samanta S., Revilla B., Suk K., Das S., Barthold S.W., Fikrig E. Borrelia burgdorferi gene expression in vivo and spirochete pathogenicity. Infect. Immun. 68:2000;1222-1230.
79. Hurtenbach U., Museteanu C., Gasser J., Schaible U.E., Simon M.M. Studies on early events of Borrelia burgdorferi-induced cytokine production in immunodeficient SCID mice by using a tissue chamber model for acute inflammation. Int. J. Exp. Pathol. 76:1995;111-123.
80. Jonsson M., Elmros T., Bergstrom S. Subcutaneous implanted chambers in different mouse strains as an animal model to study genetic stability during infection with Lyme disease Borrelia. Microb. Pathog. 18:1995;109-114.
81. Akins D.R., Bourell K.W., Caimano M.J., Norgard M.V., Radolf J.D. A new animal model for studying Lyme disease spirochetes in a mammalian host-adapted state. J. Clin. Invest. 101:1998;2240-2250.
82. Fikrig E., Chen M., Barthold S.W., Anguita J., Feng W., Telford S.R., Flavell R.A. Borrelia burgdorferi erpT expression in the arthropod vector and murine host. Mol. Microbiol. 31:1999;281-290.
83. Brown E.L., Wooten R.M., Johnson B.J., Iozzo R.V., Smith A., Dolan M.C., Guo B.P., Weis J.J., Hook M. Resistance to Lyme disease in decorin-deficient mice. J. Clin. Invest. 107:2001;845-852.
84. Grab D.J., Givens C., Kennedy R. Fibronectin-binding activity in Borrelia burgdorferi. Biochim. Biophys. Acta. 1407:1998;135-145.
85. Revel A.T., Talaat A.M., Norgard M.V. DNA microarray analysis of differential gene expression in Borrelia burgdorferi, the Lyme disease spirochete. Proc. Natl. Acad. Sci. USA. 99:2002;1562-1567.
86. de Silva A.M., Fikrig E., Hodzic E., Kantor F.S., Telford S.R. III, Barthold S.W. Immune evasion by tickborne and host-adapted Borrelia burgdorferi. J. Infect. Dis. 177:1998;395-400.
87. Zhang J.R., Hardham J.M., Barbour A.G., Norris S.J. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell. 89:1997;275-285.
88. Iyer R., Hardham J.M., Wormser G.P., Schwartz I., Norris S.J. Conservation and heterogeneity of vlsE among human and tick isolates of Borrelia burgdorferi. Infect. Immun. 68:2000;1714-1718.
89. Wang G., van Dam A.P., Dankert J. Analysis of a VMP-like sequence (vls) locus in Borrelia garinii and Vls homologues among four Borrelia burgdorferi sensu lato species. FEMS Microbiol. Lett. 199:2001;39-45.
90. Liang F.T., Nowling J.M., Philipp M.T. Cryptic and exposed invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi sl. J. Bacteriol. 182:2000;3597-3601.
91. Liang F.T., Jacobs M.B., Philipp M.T. C-terminal invariable domain of VlsE may not serve as target for protective immune response against Borrelia burgdorferi. Infect. Immun. 69:2001;1337-1343.
92. Eicken C., Sharma V., Klabunde T., Lawrenz M.B., Hardham J.M., Norris S.J., Sacchettini J.C. Crystal structure of Lyme disease variable surface antigen VlsE of Borrelia burgdorferi. J. Biol. Chem. 277:2002;21691-21696.
93. Zhang J.R., Norris S.J. Genetic variation of the Borrelia burgdorferi gene vlsE involves cassette-specific, segmental gene conversion. Infect. Immun. 66:1998;3698-3704.
94. Sung S.Y., McDowell J.V., Marconi R.T. Evidence for the contribution of point mutations to vlsE variation and for apparent constraints on the net accumulation of sequence changes in vlsE during infection with Lyme disease spirochetes. J. Bacteriol. 183:2001;5855-5861.
95. Restrepo B.I., Barbour A.G. Antigen diversity in the bacterium B. hermsii through 'somatic' mutations in rearranged vmp genes. Cell. 78:1994;867-876.
96. Kotarsky H., Hellwage J., Johnsson E., Skerka C., Svensson H.G., Lindahl G., Sjobring U., Zipfel P.F. Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. J. Immunol. 160:1998;3349-3354.
97. Neeleman C., Geelen S.P., Aerts P.C., Daha M.R., Mollnes T.E., Roord J.J., Posthuma G., van Dijk H., Fleer A. Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor, H. Infect. Immun. 67:1999;4517-4524.
98. Ram S., Sharma A.K., Simpson S.D., Gulati S., McQuillen D.P., Pangburn M.K., Rice P.A. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J. Exp. Med. 187:1998;743-752.
99. Ram S., McQuillen D.P., Gulati S., Elkins C., Pangburn M.K., Rice P.A. Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae. J. Exp. Med. 188:1998;671-680.
100. Ram S., Mackinnon F.G., Gulati S., McQuillen D.P., Vogel U., Frosch M., Elkins C., Guttormsen H.K., Wetzler L.M., Oppermann M., Pangburn M.K., Rice P.A. The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Mol. Immunol. 36:1999;915-928.
101. Diaz A., Ferreira A., Sim R.B. Complement evasion by Echinococcus granulosus: sequestration of host factor H in the hydatid cyst wall. J. Immunol. 158:1997;3779-3786.
102. China B., Sory M.P., N'Guyen B.T., De Bruyere M., Cornelis G.R. Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules. Infect. Immun. 61:1993;3129-3136.
103. Kraiczy P., Skerka C., Kirschfink M., Zipfel P.F., Brade V. Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates. Int. Immunopharmacol. 1:2001;393-401.
104. Lam T.T., Nguyen T.P., Montgomery R.R., Kantor F.S., Fikrig E., Flavell R.A. Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease. Infect. Immun. 62:1994;290-298.
105. Stevenson B., Tilly K., Rosa P.A. A family of genes located on four separate 32-kilobase circular plasmids in Borrelia burgdorferi B31. J. Bacteriol. 178:1996;3508-3516.
106. Stevenson B., Casjens S., Rosa P. Evidence of past recombination events among the genes encoding the Erp antigens of Borrelia burgdorferi. Microbiology. 144:(Pt 7):1998;1869-1879.
107. Stevenson B. Borrelia burgdorferi erp (ospE-Related) gene sequences remain stable during mammalian infection. Infect. Immun. 70:2002;5307-5311.
108. Sung S.Y., McDowell J.V., Carlyon J.A., Marconi R.T. Mutation and recombination in the upstream homology box-flanked ospE-related genes of the Lyme disease spirochetes result in the development of new antigenic variants during infection. Infect. Immun. 68:2000;1319-1327.
109. Hellwage J., Meri T., Heikkila T., Alitalo A., Panelius J., Lahdenne P., Seppala I.J., Meri S. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J. Biol. Chem. 276:2001;8427-8435.
110. Stevenson B., El-Hage N., Hines M.A., Miller J.C., Babb K. Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes. Infect. Immun. 70:2002;491-497.
111. Hubner A., Yang X., Nolen D.M., Popova T.G., Cabello F.C., Norgard M.V. Expression of Borrelia burgdorferi OspC and DbpA is controlled by a RpoN-RpoS regulatory pathway. Proc. Natl. Acad. Sci. USA. 98:2001;12724-12729.
112. Cassatt D.R., Patel N.K., Ulbrandt N.D., Hanson M.S. DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies. Infect. Immun. 66:1998;5379-5387.
113. Hagman K.E., Lahdenne P., Popova T.G., Porcella S.F., Akins D.R., Radolf J.D., Norgard M.V. Decorin-binding protein of Borrelia burgdorferi is encoded within a two-gene operon and is protective in the murine model of Lyme borreliosis. Infect. Immun. 66:1998;2674-2683.
114. Schwan T.G., Piesman J., Golde W.T., Dolan M.C., Rosa P.A. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. USA. 92:1995;2909-2913.
115. Stevenson B., Bono J.L., Schwan T.G., Rosa P. Borrelia burgdorferi Erp proteins are immunogenic in mammals infected by tick bite, and their synthesis is inducible in cultured bacteria. Infect. Immun. 66:1998;2648-2654.
116. Yang X., Popova T.G., Hagman K.E., Wikel S.K., Schoeler G.B., Caimano M.J., Radolf J.D., Norgard M.V. Identification, characterization, and expression of three new members of the Borrelia burgdorferi Mlp (2.9) lipoprotein gene family. Infect. Immun. 67:1999;6008-6018.
117. Obonyo M., Munderloh U.G., Fingerle V., Wilske B., Kurtti T.J. Borrelia burgdorferi in tick cell culture modulates expression of Outer surface proteins A and C in response to temperature. J. Clin. Microbiol. 37:1999;2137-2141.
118. Zhang J.R., Norris S.J. Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi. Infect. Immun. 66:1998;3689-3697.
119. Anguita J., Thomas V., Samanta S., Persinski R., Hernanz C., Barthold S.W., Fikrig E. Borrelia burgdorferi-induced inflammation facilitates spirochete adaptation and variable major protein-like sequence locus recombination. J. Immunol. 167:2001;3383-3390.